Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 21 to 45

Different intracanal medicines for retreatment of lower first molars

Official title: Biological, Radiographic and Clinical Evaluation of Various Inter-Visit Root Canal Dressings in Retreatment Cases: A Randomized Controlled Clinical Trial

Run by Ain Shams University · NCT07641933 · Data updated 2026-11-12

This study tests three intracanal medications to see which best reduces inflammation, heals lesions, and relieves pain in retreatment of a lower first molar with a periapical lesion.

More Intracanal Medication trials

Quick facts

PhasePhase 1
Study typeInterventional
Ages21 Years to 45 Years
SexAll
Enrollment60 (estimated)
SponsorAin Shams University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedJune 1, 2026
Main results expectedJune 2027
Study endsAugust 2027
Registry record updatedJune 12, 2026
Trial IDNCT07641933 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 21–45 years, ASA I, with restorable lower first molars and small to medium periapical lesions undergoing retreatment.

Probably not a fit

Patients with allergies to study materials, non-restorable teeth, mobility or deep periodontal pockets, or resorption may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, single-center phase 1 interventional study comparing three intracanal medications used during retreatment of failed lower first molars with periapical lesions. Patients are allocated equally to calcium hydroxide slurry with sodium hypochlorite, calcium silicate, or calcium hydroxide as the intracanal medicament. Outcomes include inflammatory biomarker IL-1β from periapical fluids, radiographic lesion size by CBCT, and patient-reported pain scores over time. Assessments occur after the second visit (two weeks) and up to 12 months post-treatment to evaluate inflammation reduction, lesion healing, and pain trajectories.

Why it matters

Potential benefit: If successful, the preferred medicament could better control inflammation and promote faster healing after retreatment.

How similar studies have gone: Prior work suggests intracanal medications can influence inflammation and healing, but this exact multi-arm comparison in retreatment is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age: 21-45 years.
2. Medically free patients. (ASA Class 1)
3. Gender: males and females
4. Patients who are cooperative at operation and in attendance at scheduled follow-up visits.
5. Restorable root canal treated permanent lower first molars with periapical lesions.
6. Small (\<5 mm) or medium periapical lesion size (5-10 mm)

Exclusion Criteria:

1. Patients with a history of allergic reactions to any of the study materials.
2. Teeth that become non-restorable after complete caries excavation.
3. Teeth that have mobility or deep periodontal pockets.
4. Teeth with internal or external resorption.

Where it's running

  • Ain Shams University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.